Robeco Institutional Asset Management B.V. Sells 66,187 Shares of Teladoc Health, Inc. (NYSE:TDOC)

Robeco Institutional Asset Management B.V. trimmed its position in Teladoc Health, Inc. (NYSE:TDOC - Free Report) by 14.6% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 387,674 shares of the health services provider's stock after selling 66,187 shares during the period. Robeco Institutional Asset Management B.V. owned approximately 0.23% of Teladoc Health worth $8,354,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of the stock. Farrow Financial Inc. acquired a new stake in Teladoc Health during the 4th quarter worth approximately $1,682,000. Foundations Investment Advisors LLC raised its holdings in Teladoc Health by 5.2% during the 4th quarter. Foundations Investment Advisors LLC now owns 21,598 shares of the health services provider's stock worth $429,000 after buying an additional 1,072 shares during the period. Eudaimonia Partners LLC raised its holdings in Teladoc Health by 18.0% during the 4th quarter. Eudaimonia Partners LLC now owns 14,763 shares of the health services provider's stock worth $318,000 after buying an additional 2,247 shares during the period. Vise Technologies Inc. raised its holdings in Teladoc Health by 100.6% during the 4th quarter. Vise Technologies Inc. now owns 30,669 shares of the health services provider's stock worth $661,000 after buying an additional 15,379 shares during the period. Finally, Dimensional Fund Advisors LP raised its holdings in shares of Teladoc Health by 25.0% in the fourth quarter. Dimensional Fund Advisors LP now owns 3,834,422 shares of the health services provider's stock valued at $82,636,000 after purchasing an additional 767,999 shares during the last quarter. 76.82% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of research firms have recently issued reports on TDOC. SVB Leerink began coverage on shares of Teladoc Health in a report on Monday, February 26th. They issued a "market perform" rating and a $17.00 price objective on the stock. Royal Bank of Canada lowered their price objective on shares of Teladoc Health from $25.00 to $18.00 and set an "outperform" rating on the stock in a report on Friday, April 26th. Evercore ISI lowered their price objective on shares of Teladoc Health from $15.00 to $14.00 and set an "in-line" rating on the stock in a report on Friday, April 26th. DA Davidson lowered their price objective on shares of Teladoc Health from $22.00 to $18.00 and set a "neutral" rating on the stock in a report on Wednesday, February 21st. Finally, Cantor Fitzgerald assumed coverage on shares of Teladoc Health in a report on Thursday, February 29th. They issued an "overweight" rating and a $22.00 price objective on the stock. Thirteen equities research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of "Hold" and an average target price of $18.41.

Insider Transactions at Teladoc Health

In other news, COO Michael Willem Waters sold 5,793 shares of Teladoc Health stock in a transaction on Thursday, May 2nd. The stock was sold at an average price of $12.69, for a total transaction of $73,513.17. Following the completion of the sale, the chief operating officer now owns 64,881 shares of the company's stock, valued at $823,339.89. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In related news, CEO Jason N. Gorevic sold 53,755 shares of the business's stock in a transaction dated Monday, March 4th. The stock was sold at an average price of $14.52, for a total value of $780,522.60. Following the completion of the transaction, the chief executive officer now owns 653,073 shares of the company's stock, valued at $9,482,619.96. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, COO Michael Willem Waters sold 5,793 shares of the business's stock in a transaction dated Thursday, May 2nd. The shares were sold at an average price of $12.69, for a total value of $73,513.17. Following the completion of the transaction, the chief operating officer now directly owns 64,881 shares of the company's stock, valued at approximately $823,339.89. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 138,368 shares of company stock valued at $1,989,227. 0.95% of the stock is currently owned by corporate insiders.

Teladoc Health Stock Performance

TDOC stock traded down $0.44 during midday trading on Monday, reaching $12.30. 4,128,021 shares of the company were exchanged, compared to its average volume of 4,872,011. The company has a debt-to-equity ratio of 0.67, a current ratio of 3.82 and a quick ratio of 3.74. The business has a 50-day moving average price of $13.86 and a two-hundred day moving average price of $17.15. Teladoc Health, Inc. has a one year low of $11.88 and a one year high of $30.41. The firm has a market capitalization of $2.09 billion, a price-to-earnings ratio of -8.72 and a beta of 0.97.

Teladoc Health (NYSE:TDOC - Get Free Report) last released its quarterly earnings data on Thursday, April 25th. The health services provider reported ($0.49) EPS for the quarter, missing analysts' consensus estimates of ($0.47) by ($0.02). Teladoc Health had a negative return on equity of 10.13% and a negative net margin of 8.90%. The company had revenue of $646.13 million for the quarter, compared to the consensus estimate of $637.31 million. During the same period last year, the firm earned ($0.37) earnings per share. The company's revenue for the quarter was up 2.7% compared to the same quarter last year. Equities research analysts forecast that Teladoc Health, Inc. will post -1.04 EPS for the current year.

Teladoc Health Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.